March 29, 2021
Article
A new cohort assessment evidences a disparity in weight-related outcomes with the ART regimens at 18 months.
March 15, 2021
A comparative study of same-day and seven-day TB test results show there is little difference in HIV treatment adherence or outcomes at 48 weeks.
Phase 1/2 trial results showed the immunomodulary vaccine regimen could induce significant T-cell response in patients with HIV.
March 09, 2021
New research from the Emerman Lab at Fred Hutchinson shows potential for advancing HIV-1 life cycle understanding.
March 08, 2021
Presented at CROI, investigators have identified sex-modified inflammatory predictors of cardiovascular and VTE risks among patients with HIV.
February 24, 2021
Video
A talk on optimistic, but pragmatic hopes for HIV cure and vaccine research, led by federal-level experts.
February 23, 2021
Attention to the endemic virus has lessened over years, and screening and prevention access remains limited among the most at-risk groups.
February 22, 2021
A John Hopkins expert and major study leader details the evolving epidemiology of the virus.
January 21, 2021
The cabotegravir and rilpivirine formulation was approved on the basis of 2 trials assessing its viral suppression capability in 1100-plus adults with HIV.
December 14, 2020
The U.S. sentinel surveillance program is a project which monitors for antibiotic-resistant gonorrhea.
